Correlation Between Unicycive Therapeutics and Larimar Therapeutics
Can any of the company-specific risk be diversified away by investing in both Unicycive Therapeutics and Larimar Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Unicycive Therapeutics and Larimar Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Unicycive Therapeutics and Larimar Therapeutics, you can compare the effects of market volatilities on Unicycive Therapeutics and Larimar Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Unicycive Therapeutics with a short position of Larimar Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Unicycive Therapeutics and Larimar Therapeutics.
Diversification Opportunities for Unicycive Therapeutics and Larimar Therapeutics
-0.08 | Correlation Coefficient |
Good diversification
The 3 months correlation between Unicycive and Larimar is -0.08. Overlapping area represents the amount of risk that can be diversified away by holding Unicycive Therapeutics and Larimar Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Larimar Therapeutics and Unicycive Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Unicycive Therapeutics are associated (or correlated) with Larimar Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Larimar Therapeutics has no effect on the direction of Unicycive Therapeutics i.e., Unicycive Therapeutics and Larimar Therapeutics go up and down completely randomly.
Pair Corralation between Unicycive Therapeutics and Larimar Therapeutics
Given the investment horizon of 90 days Unicycive Therapeutics is expected to generate 1.02 times more return on investment than Larimar Therapeutics. However, Unicycive Therapeutics is 1.02 times more volatile than Larimar Therapeutics. It trades about 0.32 of its potential returns per unit of risk. Larimar Therapeutics is currently generating about -0.13 per unit of risk. If you would invest 48.00 in Unicycive Therapeutics on September 5, 2024 and sell it today you would earn a total of 23.00 from holding Unicycive Therapeutics or generate 47.92% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Unicycive Therapeutics vs. Larimar Therapeutics
Performance |
| Timeline |
| Unicycive Therapeutics |
| Larimar Therapeutics |
Unicycive Therapeutics and Larimar Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Unicycive Therapeutics and Larimar Therapeutics
The main advantage of trading using opposite Unicycive Therapeutics and Larimar Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Unicycive Therapeutics position performs unexpectedly, Larimar Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Larimar Therapeutics will offset losses from the drop in Larimar Therapeutics' long position.| Unicycive Therapeutics vs. Transcode Therapeutics | Unicycive Therapeutics vs. Cardio Diagnostics Holdings |
| Larimar Therapeutics vs. Candel Therapeutics | Larimar Therapeutics vs. Cingulate Warrants | Larimar Therapeutics vs. Unicycive Therapeutics | Larimar Therapeutics vs. Cardio Diagnostics Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Other Complementary Tools
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Global Correlations Find global opportunities by holding instruments from different markets |